BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Flagship Pioneering

1 post

Flagship Pioneering is a life sciences venture capital firm based in Cambridge, Massachusetts that invests in biotechnology, health and sustainability firms.

Portfolio companies in the Human Health vertical include:

Axcella Therapeutics

Cellarity

Codiak Biosciences

Cygnal Therapeutics

Denali Therapeutics

Evelo Biosciences

Foghorn Therapeutics

Generate Biomedicines

Incredible Foods

Inzen Therapeutics

Kaleido Biosciences

KSQ Therapeutics

Laronde

Moderna

Omega Therapeutics

Repertoire Immune Medicines

Ring Therapeutics

Rubius Therapeutics

Sana Biotechnology

Senda Biosciences

Seres Therapeutics

Sigilon Therapeutics

Syros Pharmaceuticals

Tessera Therapeutics

Valo

Cellarity-Expands-Leadership-Team-to-Continue-Evolution-of-Breakthrough-Platform-to-Encode-Biology-and-Purposefully-Create-New-DrugsCellarity-Expands-Leadership-Team

Biotech NewsCellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs

  • BioTech Health X
  • February 10, 2022
With the appointments of these experts, the firm has added to its industry knowledge, including Chief Scientific Officer…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • CeriBell (CBLL) is a Smart MedTech Play in 2025
  • CAMP4 Therapeutics (CAMP) is Game-Changer in RNA-Driven Drug Discovery
  • Upstream Bio (UPB) is Poised to Disrupt the Respiratory Disease Market
  • Septerna (SEPN) & Novo Nordisk Join Forces to Target Obesity & Diabetes
  • Zenas BioPharma (ZBIO) is a Rising Star in Autoimmune Drug Development
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • May 30, 2025
    CeriBell (CBLL) is a Smart MedTech Play in 2025
    • May 30, 2025
    CAMP4 Therapeutics (CAMP) is Game-Changer in RNA-Driven Drug Discovery
    • May 30, 2025
    Upstream Bio (UPB) is Poised to Disrupt the Respiratory Disease Market
    • May 30, 2025
    Septerna (SEPN) & Novo Nordisk Join Forces to Target Obesity & Diabetes
    • May 30, 2025
    Zenas BioPharma (ZBIO) is a Rising Star in Autoimmune Drug Development
Recent Posts
  • MBX Biosciences Is Building the Future of Hormone Therapy
    • May 30, 2025
  • Bicara Therapeutics (BCAX) is a High-Potential Biotech Stock in 2025
    • May 30, 2025
  • Crinetics Pharmaceuticals (CRNX) Could Be the Next Biotech Breakout
    • May 30, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (155)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top